| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
REVIEWS |
From the Evidence-Based Practice Center, Center for Clinical Health Policy Research, Department of Obstetrics and Gynecology, and Division of General Internal Medicine, Department of Medicine, Duke University Medical Center, Durham, North Carolina; and Division of General Internal Medicine, Durham Veteran’s Affairs Medical Center, Durham, North Carolina
Address reprint requests to: Evan R. Myers, MD, MPH, Duke University Medical Center, Department of Obstetrics and Gynecology, Box 3279, Durham, NC 27710; E-mail: myers008{at}mc.duke.edu.
OBJECTIVE: To systematically review the literature on the surgical and nonsurgical management of uterine leiomyomata.
DATA SOURCES: Published literature in English on the management of uterine leiomyomata published from 1975 through 2000 was identified in MEDLINE, CINAHL, CancerLit, EMBASE, HealthSTAR, and the Cochrane Database of Systematic Reviews. Search terms included "leiomyomata," "fibroids," "hysterectomy," and "myomectomy."
STUDY SELECTION: Study designs considered included controlled trials, prospective trials with historical controls, prospective or retrospective cohort studies, and series with at least 20 cases. Original research studies or relevant reviews were included if the study population included women with uterine leiomyomata, and data were provided relevant to one or more of nine prespecified research questions.
TABULATION, INTEGRATION, AND RESULTS: Inconsistency in reporting of severity of symptoms, uterine anatomy, and response to therapy prevented meaningful comparison of studies in most cases, and prevented performance of meta-analysis in all cases. This was true of both surgical and nonsurgical treatments.
CONCLUSION: The available evidence on the management of uterine leiomyomata is of poor quality. Patients, clinicians, and policymakers do not have the data needed to make informed decisions about appropriate treatment. Given the prevalence of this condition and its substantial impact on women’s lives, obtaining these data should be a high research priority.
This article has been cited by other articles:
|
|
 |
|
  S. C. Goodwin, J. B. Spies, R. Worthington-Kirsch, E. Peterson, G. Pron, S. Li, E. R. Myers, and for the Fibroid Registry for Outcomes Data (FIBROI Uterine Artery Embolization for Treatment of Leiomyomata: Long-Term Outcomes From the FIBROID Registry Obstet. Gynecol., January 1, 2008; 111(1): 22 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Somigliana, P. Vercellini, R. Daguati, R. Pasin, O. De Giorgi, and P.G. Crosignani Fibroids and female reproduction: a critical analysis of the evidence Hum. Reprod. Update, September 1, 2007; 13(5): 465 - 476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Stewart, B. Gostout, J. Rabinovici, H. S. Kim, L. Regan, C. M. C. Tempany, and for the Magnetic Resonance Imaging Guided Focused Sustained Relief of Leiomyoma Symptoms by Using Focused Ultrasound Surgery Obstet. Gynecol., August 1, 2007; 110(2): 279 - 287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Scheurig, A. Gauruder-Burmester, C. Kluner, R. Kurzeja, A. Lembcke, E. Zimmermann, B. Hamm, and T. Kroencke Uterine artery embolization for symptomatic fibroids: short-term versus mid-term changes in disease-specific symptoms, quality of life and magnetic resonance imaging results Hum. Reprod., December 1, 2006; 21(12): 3270 - 3277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Casele, J. Mandel, and K. C. Williams Arm Swelling in Pregnancy Obstet. Gynecol., December 1, 2005; 106(6): 1388 - 1391. [Full Text] [PDF]
|
|
|
|
|
|
E. R. Myers, S. Goodwin, W. Landow, M. Mauro, E. Peterson, G. Pron, J. B. Spies, R. Worthington-Kirsch, and for the FIBROID Investigators Prospective Data Collection of a New Procedure by a Specialty Society: The FIBROID Registry Obstet. Gynecol., July 1, 2005; 106(1): 44 - 51. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Worthington-Kirsch, J. B. Spies, E. R. Myers, J. Mulgund, M. Mauro, G. Pron, E. D. Peterson, S. Goodwin, and for the FIBROID Investigators The Fibroid Registry for Outcomes Data (FIBROID) for Uterine Embolization: Short-Term Outcomes Obstet. Gynecol., July 1, 2005; 106(1): 52 - 59. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Chwalisz, M. C. Perez, D. DeManno, C. Winkel, G. Schubert, and W. Elger Selective Progesterone Receptor Modulator Development and Use in the Treatment of Leiomyomata and Endometriosis Endocr. Rev., May 1, 2005; 26(3): 423 - 438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hanafi Predictors of Leiomyoma Recurrence After Myomectomy Obstet. Gynecol., April 1, 2005; 105(4): 877 - 881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Shushan, N. Rojansky, N. Laufer, B. Y. Klein, Z. Shlomai, R. Levitzki, Z. Hartzstark, and H. Ben-Bassat The AG1478 tyrosine kinase inhibitor is an effective suppressor of leiomyoma cell growth Hum. Reprod., September 1, 2004; 19(9): 1957 - 1967. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Steinauer, E. A. Pritts, R. Jackson, and A. F. Jacoby Systematic Review of Mifepristone for the Treatment of Uterine Leiomyomata Obstet. Gynecol., June 1, 2004; 103(6): 1331 - 1336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Learman, R. L. Summitt Jr, R. E. Varner, S. G. McNeeley, D. Goodman-Gruen, H. E. Richter, F. Lin, J. Showstack, C. C. Ireland, E. Vittinghoff, et al. A Randomized Comparison of Total or Supracervical Hysterectomy: Surgical Complications and Clinical Outcomes Obstet. Gynecol., September 1, 2003; 102(3): 453 - 462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Myers Uterine Artery Embolization: What More Do We Need to Know? Obstet. Gynecol., November 1, 2002; 100(5): 847 - 848. [Full Text] [PDF]
|
|
|
|
|
|
D. S. Guzick So Many Studies, So Little Insight Obstet. Gynecol., July 1, 2002; 100(1): 1 - 2. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
